Health Care Equipment(IN20252.HK)

Last Updated 08:00:00
longbridge loading
Company Encyclopedia
View More
name
Health Care Equipment
IN20252.HK
News
View More

Morning Trend | EDGE MEDICAL leads the surge with increased volume, and the pharmaceutical sector shows widening divergence

EDGE MEDICAL-B (2675.HK) saw a significant increase in trading volume yesterday, forming a golden cross on the daily chart, with the MACD opening above the zero line, confirming a short-term bullish pattern. The K-line recorded a strong bullish candle, breaking through the resistance of the 5-day and 10-day moving averages, with significant inflow of main funds, indicating a strong willingness to participate. The pharmaceutical sector is showing high differentiation overall, with structural market conditions and sector rotation intensifying, as market funds tentatively position themselves in emerging innovative drug targets. From a technical perspective, the moving average system shows a bullish arrangement, with strong support built on the short-term technical front; intraday trading volume is active, and there are clear signs of funds clustering. If the volume continues to cooperate, there is a chance to challenge previous highs in the future. However, the divergence within the sector is increasing, and the risk of fund outflow from some high-priced stocks cannot be ignored. In terms of the industry environment, the medical innovative drug sector is supported by policies, driven by research and development progress and performance improvement, attracting long-term funds for increased allocation. Short-term fluctuations are mainly due to the switching of hot topics and the accelerated rhythm of sector rotation, necessitating caution against high-level funds realizing floating profits. Operational advice: Right-side traders should pay attention to the support situation when the price pulls back to the 5-day moving average during the day and participate appropriately in swing opportunities. Monitor the cooperation of main funds and intraday anomalies, and be cautious of the risk of reversal in internal sector sentiment leading to profit-taking. From a medium to long-term perspective, one should carefully assess the matching degree of valuation and fundamentals, and implement dynamic risk management. Industry risks include policy fluctuations, research and development progress falling short of expectations, and high valuation correction pressure. It is crucial to avoid blindly chasing highs in operations, and it is recommended to combine phased position building with stop-loss and take-profit strategies for stable participation

Technical Forecast·
HK
02675
-3.72%
Technical Forecast·
HK
02675
-3.72%

Morning Trend | EDGE MEDICAL-B fluctuates close to the ground, will the medical device main line reappear?

On January 12th, EDGE MEDICAL-B (2675.HK) continued to oscillate at low levels, with the medical device sector overall trapped in a downward cycle. The industry leaders lack performance, and there is a strong wait-and-see sentiment on the policy front. Throughout the day, the stock price repeatedly consolidated around the support level of 8 HKD, with multiple technical indicators such as MACD, RSI, and Bollinger Bands continuing to weaken, making it difficult to confirm bottom signals. Without the stimulation of collective procurement winning bids or significant new product launches, the sector lacks hotspots. Currently, mainstream funds are withdrawing, and risk appetite is recovering slowly, with small-cap medical device stocks being particularly weak. Right-side opportunities depend solely on policy or innovation-driven factors, such as collective procurement relieving pressure or accelerated approval of innovative drugs, which may lead to a short-term rebound in the sector; otherwise, the existing game of stock will be hard to change. Operational warning: After a prolonged sideways movement, sudden industry events can easily trigger a directional switch. At this stage, it is not advisable to blindly intervene on the left side; it is recommended to track the movements of industry leaders and the latest industry news, and to follow event-driven opportunities in the short term

Technical Forecast·
HK
02675
-3.72%
Technical Forecast·
HK
02675
-3.72%

CRYOFOCUS-B offers new shares at a discount of 17.79%, raising HKD 39.99 million

CRYOFOCUS-B announced that it will issue a total of 7.46 million new shares to two independent third parties, equivalent to an expanded share capital of 3.03%; the price per share is HKD 5.36, representing a discount of 17.79% compared to today's (12th) closing price. The total amount raised is HKD 39.99 million, with a net amount of HKD 39.73 million, of which 80% is intended for product research and development, production, and commercialization, as well as potential overseas business expansion for product commercialization; the remaining balance will be allocated for general working capital

AASTOCKS·
HK
06922
-0.30%
AASTOCKS·
HK
06922
-0.30%

Broncus Holding's BroncTarget System Enters NMPA Innovative Medical Device Special Review Procedure

Broncus Holding Corporation's BroncTarget® System has entered the Innovative Medical Device Special Review Procedure by China's NMPA. This system, known as the Pulmonary Radiofrequency Ablation System, is recognized for its technological originality and clinical value. A confirmatory clinical trial is ongoing across 28 hospitals in China for patient recruitment, though there is no guarantee of successful development and marketing.

Reuters·
HK
02216
-0.82%
Reuters·
HK
02216
-0.82%

MicroTech Medical (Hangzhou) Co., Ltd. Class H (2235) Gets a Buy from Huachuang Securities

In a report released yesterday, from Huachuang Securities maintained a Buy rating on MicroTech Medical (Hangzhou) Co., Ltd. Class H, with a price target of HK$13.70.Claim 70% Off TipRanks PremiumUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential Currently, the analyst consensus on MicroTech Medical (Hangzhou) Co., Ltd. Class H is a Moderate Buy with an average price target of HK$13.70.

Tip Ranks·
HK
02235
-0.26%
Tip Ranks·
HK
02235
-0.26%
Posts
View More

$Amazon(AMZN.US) will likely announce between 12 AM and 2:30 AM tonight,

the new Nova AI model + in-house Trainium 3 chip

Given Alibaba and Google's stock rose after announcing new models, mindlessly go...

$Nova Lifestyle(NVFY.US)💎 NVFY (Nova Lifestyle) — Order Book Snapshot 💎

📈 Latest Price: $5.42

📊 Buy Orders: 300.8K shares

📊 Sell Orders: 30.7K shares

🔥 Buy-side pressure dominates with a 10:1 ratio ...

  • 0
© 2026 Longbridge｜Disclaimer